Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 444
Filter
1.
Rev Sci Instrum ; 94(12)2023 Dec 01.
Article in English | MEDLINE | ID: mdl-38156956

ABSTRACT

Laminar-type spherical diffraction gratings overcoated with carbon-based materials were designed, fabricated, and evaluated for the purpose of enhancing the analytical sensitivity of the flat-field spectrograph in a vacuum ultraviolet region of 35-110 eV. As the design benchmark for numerical calculations, diffraction efficiency (DE) and spectral flux, which are defined by the product of the DE and numerical aperture and correlate with the analytical sensitivity of the spectrograph, were used. To simplify the feasibility study on the overcoating effects, we assumed a laminar-type grating having a grating constant of 1/1000 mm and coated with a Au layer of 30.0 nm thickness and an incidence angle of 84.0°. The optimized groove depth and duty ratio were 30.0 nm and 0.3, respectively. In addition, the optimum thicknesses of the overcoating layer were 44, 46, 24, and 30 nm for B4C, C, diamond-like-carbon, and SiC, respectively. Based on these results, we have fabricated a varied-line-spacing holographic grating overcoated with B4C with a thickness of 47 nm. For the experimental evaluation, we used the light source of Mg-L and Al-L emissions excited by the electron beam generated from an electron microscope, an objective flat-field spectrograph, and a CCD imaging detector. The experimental results showed that the spectrograph employing a new grating overcoated with the B4C layer indicated almost the same spectral resolution and 2.9-4.2 times higher analytical sensitivity compared with those obtained with a previously designed Au-coated grating having a grating constant of 1/1200 mm and used at an incidence of 86.0°.

2.
ESMO Open ; 6(6): 100330, 2021 12.
Article in English | MEDLINE | ID: mdl-34847382

ABSTRACT

BACKGROUND: Hepatocellular carcinoma (HCC) treatment remains a big challenge in the field of oncology. The liver disease (viral or not viral) underlying HCC turned out to be crucial in determining the biologic behavior of the tumor, including its response to treatment. The aim of this analysis was to investigate the role of the etiology of the underlying liver disease in survival outcomes. PATIENTS AND METHODS: We conducted a multicenter retrospective study on a large cohort of patients treated with lenvatinib as first-line therapy for advanced HCC from both Eastern and Western institutions. Univariate and multivariate analyses were performed. RESULTS: Among the 1232 lenvatinib-treated HCC patients, 453 (36.8%) were hepatitis C virus positive, 268 hepatitis B virus positive (21.8%), 236 nonalcoholic steatohepatitis (NASH) correlate (19.2%) and 275 had other etiologies (22.3%). The median progression-free survival (mPFS) was 6.2 months [95% confidence interval (CI) 5.9-6.7 months] and the median overall survival (mOS) was 15.8 months (95% CI 14.9-17.2 months). In the univariate analysis for OS NASH-HCC was associated with longer mOS [22.2 versus 15.1 months; hazard ratio (HR) 0.69; 95% CI 0.56-0.85; P = 0.0006]. In the univariate analysis for PFS NASH-HCC was associated with longer mPFS (7.5 versus 6.5 months; HR 0.84; 95% CI 0.71-0.99; P = 0.0436). The multivariate analysis confirmed NASH-HCC (HR 0.64; 95% CI 0.48-0.86; P = 0.0028) as an independent prognostic factor for OS, along with albumin-bilirubin (ALBI) grade, extrahepatic spread, neutrophil-to-lymphocyte ratio, portal vein thrombosis, Eastern Cooperative Oncology Group (ECOG) performance status and alpha-fetoprotein. An interaction test was performed between sorafenib and lenvatinib cohorts and the results highlighted the positive predictive role of NASH in favor of the lenvatinib arm (P = 0.0047). CONCLUSION: NASH has been identified as an independent prognostic factor in a large cohort of patients with advanced HCC treated with lenvatinib, thereby suggesting the role of the etiology in the selection of patients for tyrosine kinase treatment. If validated, this result could provide new insights useful to improve the management of these patients.


Subject(s)
Carcinoma, Hepatocellular , Liver Neoplasms , Non-alcoholic Fatty Liver Disease , Carcinoma, Hepatocellular/drug therapy , Humans , Liver Neoplasms/drug therapy , Phenylurea Compounds , Prognosis , Quinolines , Retrospective Studies
4.
Drugs Today (Barc) ; 55(4): 231-236, 2019 Apr.
Article in English | MEDLINE | ID: mdl-31050691

ABSTRACT

Dacomitinib (PF-00299804, Vizimpro) was developed as a second-generation, oral, irreversible inhibitor of human epidermal growth factor receptor (EGFR)- 1, -2 and -4 tyrosine kinase. On September 27, 2018, the United States Food and Drug Administration (FDA) approved dacomitinib for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) with EGFR exon 19 deletion or exon 21 L858R substitution mutations. On January 8, 2019, the Ministry of Health, Labour and Welfare of Japan approved this second-generation EGFR tyrosine kinase inhibitor (TKI) for the treatment of EGFR mutation-positive inoperable or recurrent NSCLC. The European Commission also approved dacomitinib on April 3, 2019, as monotherapy for the first-line treatment of adult patients with locally advanced or metastatic NSCLC with EGFR activating mutations. Approval of dacomitinib was based on a randomized, multicenter, open-label, active-controlled trial (ARCHER 1050; ClinicalTrials.gov Identifier NCT01774721) which demonstrated the safety and efficacy of dacomitinib compared to gefitinib in 452 patients with unresectable and metastatic NSCLC. Dacomitinib represents a powerful new treatment option compared with first-generation EGFR-TKIs. In this paper, we review the clinical and preclinical studies of dacomitinib and discuss the drug's clinical value.


Subject(s)
Carcinoma, Non-Small-Cell Lung/drug therapy , Lung Neoplasms/drug therapy , Protein Kinase Inhibitors/therapeutic use , Quinazolinones/therapeutic use , ErbB Receptors/antagonists & inhibitors , ErbB Receptors/genetics , Humans , Mutation , Neoplasm Recurrence, Local , Protein-Tyrosine Kinases/antagonists & inhibitors , Randomized Controlled Trials as Topic
5.
Clin Exp Immunol ; 195(1): 86-95, 2019 01.
Article in English | MEDLINE | ID: mdl-30178467

ABSTRACT

Soyasaponins (SSs) are abundant in soybeans and display inhibitory activity against contact hypersensitivity (CHS), which is often used as a mouse model for allergic contact dermatitis (ACD); however, their therapeutic mechanisms remain unknown. Here, we attempted to clarify the role of gut microbiota in the inhibition of CHS by dietary soyasaponins. For antibiotic treatment, mice were administered a mixture of ciprofloxacin and metronidazole or vancomycin. These antibiotics and SSs were given to mice via drinking water 3-weeks prior to CHS induction with 2,4-dinitrofluorobenzene, and the mice were analysed for ear swelling, tissue oedema, infiltration of Gr-1-positive immune cells, the composition of faecal microbiota and regulatory T (Treg ) cells. The soyasaponin diets attenuated ear swelling and tissue oedema, and reduced the number of Gr-1-positive cells infiltrating ear tissues. CHS caused changes in the structure of the gut microbiota, but dietary SSs blocked the changes in the microbiota composition. Ciprofloxacin and metronidazole treatments significantly enhanced the severity of CHS symptoms, whereas vancomycin treatment blocked the suppressive effect of dietary SSs on CHS. These antibiotic treatments differed in their effects on the gut microbiota composition. Treg cells in auricular lymph node and spleen increased under SS-enriched diets, but this increase was blocked by vancomycin treatment. These results suggest that dietary SSs exert their inhibitory activity on CHS via the gut microbiota in mice, suggesting that dietary supplementation with SSs may have beneficial effects on ACD patients, but that the gut microbiota is a critical determinant of the therapeutic value of dietary SSs.


Subject(s)
Dermatitis, Allergic Contact/therapy , Dermatitis, Contact/therapy , Gastrointestinal Microbiome/immunology , Saponins/therapeutic use , T-Lymphocytes, Regulatory/immunology , Animals , Anti-Bacterial Agents/therapeutic use , Cells, Cultured , Diet , Dinitrofluorobenzene/analogs & derivatives , Disease Models, Animal , Edema , Female , Humans , Mice , Mice, Inbred BALB C , Glycine max/immunology
6.
J Microbiol Methods ; 117: 4-10, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26159910

ABSTRACT

UNLABELLED: An important goal for the improved diagnosis and management of infectious and inflammatory diseases, such as periodontitis, is the development of rapid and accurate technologies for the decentralized detection of bacterial pathogens. The aim of this prospective multicenter study was to evaluate the clinical use of a novel immunochromatographic device with monoclonal antibodies for the rapid point-of-care detection and semi-quantification of Porphyromonas gingivalis in subgingival plaque. Sixty-three patients with chronic periodontitis and 28 periodontally healthy volunteers were subjected to clinical and microbiological examinations. Subgingival plaque samples were analyzed for the presence of P. gingivalis using a novel immunochromatography based device DK13-PG-001, designed to detect the 40k-outer membrane protein of P. gingivalis, and compared with a PCR-Invader method. In the periodontitis group, a significant strong positive correlation in detection results was found between the test device score and the PCR-Invader method (Spearman rank correlation, r=0.737, p<0.0001). The sensitivity, specificity, and positive and negative predictive values of the test device were 96.2%, 91.8%, 90.4% and 96.7%, respectively. The detection threshold of the test device was determined to be approximately 10(4) (per two paper points). There were significant differences in the bacterial counts by the PCR-Invader method among groups with different ranges of device scores. With a cut-off value of ≥0.25 in device score, none of periodontally healthy volunteers were tested positive for the subgingival presence of P. gingivalis, whereas 76% (n=48) of periodontitis subjects were tested positive. There was a significant positive correlation between device scores for P. gingivalis and periodontal parameters including probing pocket depth and clinical attachment level (r=0.317 and 0.281, respectively, p<0.01). The results suggested that the DK13-PG-001 device kit can be effectively used for rapid, chair-side detection and semi-quantification of P. gingivalis in subgingival plaque. TRIAL REGISTRATION: UMIN Clinical Trials Registry (UMIN-CTR) UMIN000011943.


Subject(s)
Bacteriological Techniques/instrumentation , Chromatography, Affinity/instrumentation , Dental Plaque/microbiology , Porphyromonas gingivalis/isolation & purification , Adult , Aged , Aged, 80 and over , Antibodies, Bacterial , Antibodies, Monoclonal , Bacteriological Techniques/methods , Chromatography, Affinity/methods , Equipment Design , Female , Humans , Male , Middle Aged , Periodontitis/microbiology , Point-of-Care Systems , Porphyromonas gingivalis/immunology , Predictive Value of Tests , Prospective Studies
7.
Aust Dent J ; 60(4): 503-10, 2015 12.
Article in English | MEDLINE | ID: mdl-25439282

ABSTRACT

BACKGROUND: Full-mouth scaling and root planing combined with azithromycin is clinically and bacteriologically effective for the treatment of chronic periodontitis. This study aimed to investigate the clinical and bacteriological effects of this combination treatment in patients with peri-implantitis. METHODS: Twenty adult patients with both chronic periodontitis and peri-implantitis were randomly divided into two groups (10: test, 10: control). All patients underwent full-mouth scaling and root planing but the test group received azithromycin for 3 days before the procedure. The probing depth, bleeding on probing, and the gingival index were assessed clinically. Bacterial samples were obtained before treatment at 1 week and 1, 3, 6, 9 and 12 months after treatment. Quantitative and qualitative analyses were performed using the polymerase chain reaction Invader method. RESULTS: All clinical parameters showed better improvement in both periodontitis and peri-implantitis in the test group. Periodontal bacteria were more effectively reduced in the test group, but gradually increased around implants 6 months after treatment and natural teeth 9 months after treatment. CONCLUSIONS: Full-mouth scaling and root planing combined with azithromycin was temporarily useful for the treatment of peri-implantitis. Clinical improvements were maintained for about 9 months but periodontal bacteria increased again 6 months after treatment.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Azithromycin/therapeutic use , Dental Scaling/methods , Peri-Implantitis/drug therapy , Root Planing/methods , Aged , Chronic Periodontitis/drug therapy , Female , Humans , Male , Middle Aged , Peri-Implantitis/physiopathology , Periodontal Index
8.
Eur J Gynaecol Oncol ; 35(4): 473-6, 2014.
Article in English | MEDLINE | ID: mdl-25118497

ABSTRACT

Adenosarcoma of the uterine body is a rare mixed tumor in which a benign epithelial component is mixed with a malignant stromal element. It has been considered that this tumor originates from the endometrium and its most common finding of imaging is a polypoid tumor occupying the uterine cavity. The authors herein present a case of 37-year-old female with a complaint of abnormal vaginal bleeding. At the first visit, transvaginal ultrasound and magnetic resonance imaging (MRI) showed a round mass with a diameter of one cm in the uterine wall. No malignant pathological finding was detected. The patient visited the authors again one year later, because of continuous bleeding. At that time, they found a polypoid tumor in the uterine cavity, which turned out to be adenosarcoma with sarcomatous overgrowth. The round mass in the uterus detected at first time seems to have been incipience of adenosarcoma. Prodromal sign of adenosarcoma has not been reported previously.


Subject(s)
Adenosarcoma/diagnosis , Prodromal Symptoms , Uterine Neoplasms/diagnosis , Uterus/pathology , Adenosarcoma/complications , Adenosarcoma/surgery , Adult , Female , Humans , Hysterectomy , Magnetic Resonance Imaging , Ultrasonography , Uterine Hemorrhage/etiology , Uterine Neoplasms/complications , Uterine Neoplasms/surgery , Uterus/diagnostic imaging
9.
Pharmazie ; 68(1): 54-7, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23444781

ABSTRACT

The fullerene C60 is used in consumer products such as cosmetics owing to its antioxidative effects and is being developed for nanomedical applications. However, knowledge regarding the safety of fullerene C60, especially after oral administration, is sparse. Here, we examined the safety of fullerene C60 in mice after 7 d of exposure to orally administered polyvinylpyrrolidone (PVP)-wrapped fullerene C60 (PVP-fullerene C60). Mice treated with PVP-fullerene C60 showed few changes in the plasma levels of various markers of kidney and liver injury and experienced no significant hematologic effects. Furthermore, the histology of the colon of PVP-fullerene C60-treated mice was indistinguishable from that of control mice. These results suggest that PVP-fullerene C60 lacks toxicity after high-dose oral administration and indicate that PVP-fullerene C60 can be considered safe for oral medication. These data provide basic information that likely will facilitate the production of safe and effective forms of fullerene C60.


Subject(s)
Fullerenes/pharmacology , Acute Kidney Injury/chemically induced , Acute Kidney Injury/pathology , Administration, Oral , Animals , Blood Cell Count , Chemical and Drug Induced Liver Injury/pathology , Colitis/chemically induced , Colitis/pathology , Female , Fullerenes/administration & dosage , Light , Mice , Mice, Inbred C57BL , Povidone , Scattering, Radiation , Tissue Fixation
10.
Health Phys ; 104(3): 243-50, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23361418

ABSTRACT

Because of radioactive fallout resulting from the Fukushima Daiichi Nuclear Power Plant (NPP) accident, water discharge from many outdoor swimming pools in Fukushima was suspended out of concern that radiocesium in the pool water would flow into farmlands. The Japan Atomic Energy Agency has reviewed the existing flocculation method for decontaminating pool water and established a practical decontamination method by demonstrating the process at eight pools in Fukushima. In this method, zeolite powder and a flocculant are used for capturing radiocesium present in pool water. The supernatant is discharged if the radiocesium concentration is less than the targeted level. The radioactive residue is collected and stored in a temporary storage space. Radioactivity concentration in water is measured with a NaI(Tl) or Ge detector installed near the pool. The demonstration results showed that the pool water in which the radiocesium concentration was more than a few hundred Bq L was readily purified by the method, and the radiocesium concentration was reduced to less than 100 Bq L. The ambient dose rates around the temporary storage space were slightly elevated; however, the total increase was up to 30% of the background dose rates when the residue was shielded with sandbags.


Subject(s)
Decontamination/methods , Fukushima Nuclear Accident , Schools , Swimming Pools/standards , Aluminum Hydroxide/chemistry , Cesium Radioisotopes/chemistry , Cesium Radioisotopes/isolation & purification , Decontamination/economics , Flocculation , Radiation Protection , Time Factors , Water/chemistry , Zeolites/chemistry
12.
Cell Death Dis ; 3: e313, 2012 May 24.
Article in English | MEDLINE | ID: mdl-22622132

ABSTRACT

Apoptosis is induced by various stresses generated from the extracellular and intracellular environments. The fidelity of the cell cycle is monitored by surveillance mechanisms that arrest its further progression if any crucial process has not been completed or damages are sustained, and then the cells with problems undergo apoptosis. Although the molecular mechanisms involved in the regulation of the cell cycle and that of apoptosis have been elucidated, the links between them are not clear, especially that between cell cycle and death receptor-mediated apoptosis. By using the HeLa.S-Fucci (fluorescent ubiquitination-based cell cycle indicator) cells, we investigated the relationship between the cell cycle progression and apoptotic execution. To monitor apoptotic execution during cell cycle progression, we observed the cells after induction of apoptosis with time-lapse fluorescent microscopy. About 70% of Fas-mediated apoptotic cells were present at G(1) phase and about 20% of cells died immediately after cytokinesis, whereas more than 60% of etoposide-induced apoptotic cells were at S/G(2) phases in random culture of the cells. These results were confirmed by using synchronized culture of the cells. Furthermore, mitotic cells showed the resistance to Fas-mediated apoptosis. In conclusion, these findings suggest that apoptotic execution is dependent on cell cycle phase and Fas-mediated apoptosis preferentially occurs at G(1) phase.


Subject(s)
Apoptosis , G1 Phase , fas Receptor/metabolism , Cell Division , Etoposide/pharmacology , HeLa Cells , Humans , Microscopy, Fluorescence , Mitosis , Signal Transduction
14.
Dis Esophagus ; 25(5): 381-5, 2012 Jul.
Article in English | MEDLINE | ID: mdl-21967617

ABSTRACT

Reflux esophagitis (RE) is a known complication disturbing patients' quality of life after esophageal resection. It is generally recognized that bile reflux as well as acid reflux cause RE. However, the clinical influence of acid and bile reflux, and Helicobacter pylori (H. pylori) infection on RE in the cervical esophagus after esophagectomy is not yet clarified. Sixty patients who underwent cervical esophagogastrostomy following esophagectomy were enrolled in this study. They underwent examination for H. pylori infection, endoscopic examination, and continuous 24-hour pH and bilirubin monitoring, at 1 month after surgery. The influence of acid and/or bile reflux, H. pylori infection, and others on the development of RE were investigated. RE was observed in 19 patients (32%) at 1 month after esophagogastrostomy, mild RE in 16 (27%), and severe RE in 3 (5%). The percentage of time duration of both acid and bile reflux into the cervical esophagus was higher in patients with RE than in those without (P = 0.027, P < 0.001). A significant difference in %time pH < 4 acid reflux was found between mild RE and severe RE (P = 0.014), and a statistical difference in %time abs. > 0.14 between non-RE and mild RE (P = 0.017). Acid and/or bile reflux was observed in 31 patients (52%), acid-only reflux in 6 (10%), bile-only reflux in 15 (25%), and acid-and-bile reflux in 10 (17%). Severe RE was observed only in patients having acid-and-bile reflux. On the univariate analysis, no infection of H. pylori, acid reflux, and bile reflux were determined to be the influencing factors to RE among the clinical factors including age, gender, route of esophageal reconstruction, H. pylori infection, and acid-and-bile reflux. In the subanalysis using the logistic model, there were significant correlations between bile reflux and RE irrespective of the presence of H. pylori infection (P = 0.016, P = 0.007). On the other hand, there was a significant correlation between acid reflux and RE only in patients without H. pylori infection (P = 0.039). In the early period after esophagogastrostomy, bile reflux could cause RE irrespective of H. pylori infection, while acid reflex could cause RE only in patients without H. pylori infection. There is a possibility that bile reflux plays an important role in the development of RE after esophagectomy.


Subject(s)
Duodenogastric Reflux/etiology , Esophagectomy/adverse effects , Esophagitis, Peptic/etiology , Gastroesophageal Reflux/etiology , Helicobacter Infections , Helicobacter pylori , Aged , Aged, 80 and over , Bile Reflux/etiology , Esophageal Neoplasms/surgery , Female , Follow-Up Studies , Gastric Acidity Determination , Humans , Male , Middle Aged , Risk Factors
15.
Dis Esophagus ; 24(8): E36-40, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21883655

ABSTRACT

Aortic complications after esophageal cancer surgery are rare and usually fatal. Here, we report three patients who underwent thoracic endovascular aortic repair (TEVAR) for aortic complications after esophagectomy for cancer. In the first case, aortic rupture was caused by pyothorax due to residual tumor after esophagectomy. In the second case, aortic rupture was caused by pyothorax due to anastomotic leakage. In the third case, a pseudoaneurysm was caused by surgical injury during esophagectomy. TEVAR was safe and effective for severe aortic complications when graft infection was avoided. The first case died of sepsis on the 84th postoperative day, and the other two cases have survived 4 years and 2 years to date.


Subject(s)
Aneurysm, False/etiology , Angioscopy , Aorta/surgery , Aortic Rupture/surgery , Esophageal Neoplasms/surgery , Esophagectomy/adverse effects , Aged , Aorta/injuries , Aortic Rupture/etiology , Empyema, Pleural/complications , Humans , Male , Middle Aged , Stents
16.
J Periodontal Res ; 45(5): 643-9, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20572923

ABSTRACT

BACKGROUND AND OBJECTIVE: Enamel sheath protein (ESP) is involved in the construction of the enamel sheath during tooth development. The 17 kDa ESP is a one-step cleavage product processed by proteolysis from the N-terminal side of sheathlin (ameloblastin/amelin), one of the porcine enamel matrix proteins. Enamel sheath protein exhibits periodontal ligament and cementum regeneration activity in a buccal dehiscence model in dogs, and promotes the cytodifferentiation of cultured human periodontal ligament (HPDL) cells. The aim of this study was to determine the peptide segment on the C-terminal side sequence of the human ESP that possesses a cytodifferentiation activity on cultured HPDL cells. MATERIAL AND METHODS: The peptides synthesized on the basis of human ESP C-terminal side sequence were tested for their ability to increase the alkaline phosphatase (ALP) and mineralization activity of cultured HPDL cells. The expressions of osteocalcin, osteopontin and bone sialoprotein were measured by semi-quantitative PCR and therefore were determined to be specific indicators of mineralized tissue differentiation. RESULTS: Multiple synthetic peptides from the human ESP increased the ALP activity and stimulated matrix mineralization in long-term cultures of HPDL cells. Semi-quantitative PCR demonstrated the osteocalcin, osteopontin and bone sialoprotein expressions to increase relative to the control values. The peptide SDKPPKPELPGVDF had the strongest cytodifferentiation activity among all the synthetic peptides tested. CONCLUSION: A specific peptide sequence derived from the C-terminal side of the human ESP promotes the cytodifferentiation and mineralization activity of HPDL cells in a cell culture system.


Subject(s)
Dental Enamel Proteins/chemical synthesis , Dental Enamel Proteins/physiology , Periodontal Ligament/cytology , Periodontal Ligament/drug effects , Alkaline Phosphatase/biosynthesis , Amino Acid Sequence , Animals , Calcification, Physiologic/drug effects , Cell Differentiation/drug effects , Cells, Cultured , Cementogenesis/drug effects , Cementogenesis/physiology , Dental Enamel Proteins/chemistry , Dental Enamel Proteins/pharmacology , Humans , Integrin-Binding Sialoprotein/biosynthesis , Mice , Molecular Sequence Data , Osteocalcin/biosynthesis , Osteopontin/biosynthesis , Peptide Fragments/chemical synthesis , Peptide Fragments/pharmacology , Periodontal Ligament/metabolism , Regeneration/drug effects , Regeneration/physiology
17.
Dis Esophagus ; 23(8): 646-51, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20545979

ABSTRACT

Esophageal cancer patients with distant organ metastasis have usually been treated only to palliate symptoms without multimodality therapy. The current study evaluates the role of multimodality therapy in esophageal squamous cell cancer patients with distant organ metastasis. Between February 1988 and January 2007, 80 esophageal squamous cell cancer patients with distant organ metastases were treated at our institution. Multimodality therapy was performed in 58 patients: 43 patients received chemoradiotherapy, 13 underwent surgery followed by chemotherapy and/or radiation therapy, and two received chemotherapy or chemoradiotherapy followed by surgery. Thirteen patients received single-modality therapy; chemotherapy, radiotherapy, or surgery alone. The remaining nine patients received best supportive care alone. The metastatic organ was the liver (n= 40), the lungs (n= 33), bone (n= 10), and other (n= 6). Nine patients had metastasis in two organs. There was no difference in the median survival among the sites of organ metastasis, lung, liver, or bone (P= 0.8786). The survival of patients treated with multimodality therapy was significantly better than that of the patients who received single-modality therapy or best supportive care alone (P < 0.0001). In patients treated with multimodallity therapy, there was no difference in survival for patients treated with surgery compared with patients treated without surgery (P= 0.1291). This retrospective study involves an inevitable issue of patient selection bias. However, these results suggested that multimodality therapy could improve survival of the esophageal squamous cell cancer patients with distant organ metastasis.


Subject(s)
Bone Neoplasms/secondary , Carcinoma, Squamous Cell/secondary , Esophageal Neoplasms/mortality , Liver Neoplasms/secondary , Lung Neoplasms/secondary , Palliative Care , Adult , Aged , Aged, 80 and over , Antineoplastic Combined Chemotherapy Protocols , Combined Modality Therapy , Esophageal Neoplasms/drug therapy , Esophageal Neoplasms/pathology , Esophageal Neoplasms/radiotherapy , Esophageal Neoplasms/surgery , Female , Humans , Male , Middle Aged , Neoplasm Staging , Patient Selection , Retrospective Studies , Survival Rate , Treatment Outcome
18.
Sci Total Environ ; 408(16): 3319-26, 2010 Jul 15.
Article in English | MEDLINE | ID: mdl-20417547

ABSTRACT

Seasonal changes in the impacts of fertilizer on the composition of agricultural drainage water were examined by analyzing the (87)Sr/(86)Sr isotope ratio and chemical composition of drainage water samples. Samples of drainage water were taken from the main drainage canals of the Lower Seyhan Irrigation Project, at sites designated as D10, D11, and D12. Plots of (87)Sr/(86)Sr vs. 1/Sr indicated that the (87)Sr/(86)Sr ratio of drainage water was positively related to those of fertilizer and irrigation water. The origins of Sr in two of the end-components were fertilizer and irrigation water. The data from the end-drain in winter suggested that the origin of Sr in the third end-component was fossil seawater. Analysis of a mixing model incorporating these three end-components showed that the origins of Sr in drainage differed markedly between summer and winter. Fertilizer made the greatest contribution to Sr in drainage water both in summer and winter, contributing 38-72% of total Sr in summer and 64-87% of total Sr in winter. In summer, fertilizer contributed 72% of total Sr in drainage water in D12, 44% in D10, and 38% in D11. This result implies that fertilizer was applied excessively at the D12 site. In winter, seawater accounted for 10% of Sr in drainage water in D12, whereas it accounted for 19-27% of Sr in drainage water in D10 and D11. Therefore, at least 70% of the salt in drainage water originates from fertilizer and irrigation water. At this study site, the salt originating from seawater is replaced by that from fertilizer and irrigation water, due to intensive agricultural management. The study site is a delta that lay on the ocean subsurface at least 3000years ago, and therefore, was originally a primary salinization area. This result suggests that anthropogenic secondary salinization progressed over time via fertilizer and irrigation applications.


Subject(s)
Agriculture , Fertilizers , Seasons , Sodium Chloride , Turkey
19.
Dis Esophagus ; 23(6): 502-5, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20113319

ABSTRACT

Esophageal small cell carcinoma (SmCC) has been regarded as a rare and aggressive tumor with early metastasis. The optimal treatment has not yet been established, and the role of surgery has remained controversial. In this retrospective study, we report seven cases studies of SmCC of the esophagus and analyze the clinical outcomes after surgery. Between 1986 and 2007, there were seven patients with esophageal SmCC treated surgically in our institution. All the patients with clinically limited disease underwent transthoracic esophagectomy with lymphadenectomy. Lymph node involvement was found in all cases irrespective of the depth of tumor invasion. Three of the seven patients were diagnosed as having an extensive disease on pathological examination after esophagectomy. Five patients received postoperative chemotherapy. Two patients are alive with no recurrence at 16 months and at 45 months after surgery. Another one without chemotherapy survived 93 months and died of another disease. The remaining four patients died of recurrent disease or another disease. The median overall survival to date of these patients was 16 months (range 12-93 months). Esophagectomy with lymphadenectomy resulted in a relatively better survival in some patients with esophageal SmCC. We concluded that surgery may be helpful as part of multimodality treatment in selected patients with esophageal SmCC.


Subject(s)
Carcinoma, Small Cell/surgery , Esophageal Neoplasms/surgery , Aged , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoma, Small Cell/drug therapy , Carcinoma, Small Cell/mortality , Cisplatin/administration & dosage , Combined Modality Therapy , Esophageal Neoplasms/drug therapy , Esophageal Neoplasms/mortality , Esophagectomy , Etoposide/administration & dosage , Female , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Retrospective Studies , Treatment Outcome
20.
Dis Esophagus ; 23(5): 353-60, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20113323

ABSTRACT

Pharyngolaryngeal reflux has been generally accepted as a cause for pharyngolaryngitis, hoarseness, aspiration pneumonia, chronic cough, and nocturnal asthma. Although patients who have undergone gastric conduit reconstruction after esophagectomy are at a high risk to pharyngolaryngeal reflux disease (PLRD), PLRD after esophagectomy is still unknown. The aim of this study is to investigate the correlation between reflux pharyngolaryngitis and acid reflux into the hypopharynx and into the cervical esophagus in patients who have undergone cervical esophagogastrostomy. We enrolled 62 patients who received follow-up endoscopy and 24-h pH monitoring after cervical esophagogastrostomy. These included 26 at 1 month after surgery and 36 at 1 year or more after surgery. We investigated: (i) the correlation between the extent of reflux pharyngolaryngitis and that of reflux esophagitis based on endoscopic findings; and (ii) the correlation between the extent of reflux pharyngolaryngitis and that of acid exposure -'% time pH < 4' measured by 24-h pH monitoring - in the hypopharynx and in the cervical esophagus, and of acidity in the gastric conduit. There was no difference in acid exposure between the hypopharynx and the cervical esophagus according to time after surgery. However, the acidity in the gastric conduit was significantly more at one year or more after surgery compared with acidity at 1 month after surgery (P= 0.001). There was a significant correlation between acid exposure in the hypopharynx and that in the cervical esophagus (P < 0.001), although acid exposure in the hypopharynx was significantly less than that in the cervical esophagus (P < 0.001). A significant correlation between reflux pharyngolaryngitis and reflux esophagitis was observed (P < 0.001). There was a significant correlation between reflux pharyngolaryngitis and acid exposure in the hypopharynx (P= 0.021), and also that in the proximal esophagus (P= 0.001). The correlation between the extent of reflux pharyngolaryngitis and the acidity in the gastric conduit was not observed. These findings are consistent with pharyngolaryngitis being caused by gastro-esophago-pharyngolaryngeal reflux in patients after cervical esophagogastrostomy, despite the upper esophageal sphincter strongly preventing acid reflux from the cervical esophagus into the hypopharynx.


Subject(s)
Esophagitis, Peptic/etiology , Esophagoplasty/adverse effects , Esophagostomy/adverse effects , Gastrostomy/adverse effects , Laryngitis/etiology , Laryngopharyngeal Reflux/complications , Pharyngitis/etiology , Adult , Aged , Aged, 80 and over , Esophageal Neoplasms/surgery , Esophagectomy , Esophagostomy/methods , Female , Gastric Acidity Determination , Humans , Hypopharynx/pathology , Laryngopharyngeal Reflux/etiology , Male , Middle Aged , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...